MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quality of Life in Parkinson’s Disease: Impact of Depression and Apathy

H. Nagayama (Tokyo, Japan)

Meeting: 2018 International Congress

Abstract Number: 1594

Keywords: Apathy, Depression

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: The aim of this study is to investigate whether depression and apathy are independently related to QoL in patients with PD. Therefore, we performed a multivariate analysis of widely used tests of numerous factors, including depression and apathy, that might affect QoL.

Background: Many nonmotor symptoms, such as apathy and depression, are observed in patients with Parkinson’s disease (PD). Depression has a major impact on health-related quality of life (QoL). However, no studies have evaluated depression and apathy in patients with PD using multivariate analyses and an appropriate battery of tests of numerous factors, such as symptom severity and age, that might be related to QoL in PD.

Methods: A cross-sectional multicenter study was performed in 14 Japanese centers. Patients with PD (n = 314) and mini-mental state examination scores of 23 or more were recruited. The patients with PD completed the 36-item Short-Form Health Survey (SF-36), Beck Depression Inventory-2nd edition (BDI), and Apathy Scale. The scores were used to measure their QoL and symptoms of depression and apathy. A multiple regression analysis is performed to test the influence of 16 factors, including depression and apathy, on each domain of the SF-36, and the differences in the effects of depression and apathy on QoL are assessed.

Results: The BDI and Apathy Scale scores were significant independent variables in most SF-36 domains. However, their tendencies differed. BDI scores were significantly related to most SF-36 domains, especially the mental component. In contrast, Apathy Scale scores tended to be related to the physical component.

Conclusions: These results suggested that depression and apathy were significantly and independently associated with different QoL domains in patients with PD. These findings suggest that different strategies should be used to treat patients in these states.

To cite this abstract in AMA style:

H. Nagayama. Quality of Life in Parkinson’s Disease: Impact of Depression and Apathy [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/quality-of-life-in-parkinsons-disease-impact-of-depression-and-apathy/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/quality-of-life-in-parkinsons-disease-impact-of-depression-and-apathy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley